ZA924517B - Aminomethyl-substituted 2,3-dihydropyrano(2,3-b)pyridines,process for their preparation and their use in medicaments - Google Patents

Aminomethyl-substituted 2,3-dihydropyrano(2,3-b)pyridines,process for their preparation and their use in medicaments

Info

Publication number
ZA924517B
ZA924517B ZA924517A ZA924517A ZA924517B ZA 924517 B ZA924517 B ZA 924517B ZA 924517 A ZA924517 A ZA 924517A ZA 924517 A ZA924517 A ZA 924517A ZA 924517 B ZA924517 B ZA 924517B
Authority
ZA
South Africa
Prior art keywords
dihydropyrano
pyridines
substituted
aminomethyl
medicaments
Prior art date
Application number
ZA924517A
Other languages
English (en)
Inventor
Dieter Arlt
Arlt Dieter
Hans-Georg Heine
Heine Hans-Georg
Rudolf Schohe-Loop
Schohe-Loop Rudolf
Thomas Glaser
Glaser Thomas
Jean Marie Viktor De Vry
Marie Viktor De Vry Jean
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA924517B publication Critical patent/ZA924517B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA924517A 1991-06-20 1992-06-19 Aminomethyl-substituted 2,3-dihydropyrano(2,3-b)pyridines,process for their preparation and their use in medicaments ZA924517B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4120322A DE4120322A1 (de) 1991-06-20 1991-06-20 Aminomethyl-substituierte 2,3-dihydropyrano(2,3-b)pyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
ZA924517B true ZA924517B (en) 1993-03-31

Family

ID=6434336

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA924517A ZA924517B (en) 1991-06-20 1992-06-19 Aminomethyl-substituted 2,3-dihydropyrano(2,3-b)pyridines,process for their preparation and their use in medicaments

Country Status (24)

Country Link
US (1) US5250540A (xx)
EP (1) EP0519291B1 (xx)
JP (1) JP3135170B2 (xx)
KR (1) KR930000520A (xx)
CN (1) CN1067656A (xx)
AT (1) ATE147388T1 (xx)
AU (1) AU649331B2 (xx)
CA (1) CA2071398A1 (xx)
CZ (1) CZ177892A3 (xx)
DE (2) DE4120322A1 (xx)
DK (1) DK0519291T3 (xx)
ES (1) ES2095984T3 (xx)
FI (1) FI922874A (xx)
GR (1) GR3022557T3 (xx)
HU (1) HU209890B (xx)
IE (1) IE922004A1 (xx)
IL (1) IL102227A0 (xx)
MX (1) MX9202983A (xx)
NO (1) NO922198L (xx)
NZ (1) NZ243191A (xx)
RU (1) RU2044737C1 (xx)
SK (1) SK177892A3 (xx)
TW (1) TW221439B (xx)
ZA (1) ZA924517B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ271383A (en) * 1993-08-19 1997-05-26 Janssen Pharmaceutica Nv 3,4-dihydro-2h-pyrano[2,3-b]-pyridinyl derivatives; intermediates
BR9810842A (pt) 1997-07-31 2000-07-25 Du Pont Pharm Co Processo para a sìntese de ciclopropilacetileno e composto
US6235957B1 (en) 1998-06-29 2001-05-22 Dupont Pharmaceuticals Company Process for the preparation of cyclopropylacetylene
AU4698299A (en) 1998-06-30 2000-01-17 Du Pont Pharmaceuticals Company 5-HT7 receptor antagonists
AU6281199A (en) 1998-10-01 2000-04-17 Du Pont Pharmaceuticals Company Process for the preparation of cyclopropylacetylene
US6288297B1 (en) 1998-10-01 2001-09-11 Dupont Pharmaceuticals Company Process for the preparation of cyclopropylacetylene
JP2001131177A (ja) * 1999-11-08 2001-05-15 Ohara Yakuhin Kogyo Kk ジベンズ［ｃ，ｆ］イミダゾ［１，５−ａ］アゼピンの製造方法及びその製造中間体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
CA2015296C (en) * 1989-05-31 2001-08-07 Karnail Atwal Pyranyl cyanoguanidine derivatives
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.

Also Published As

Publication number Publication date
SK177892A3 (en) 1995-03-08
HU209890B (en) 1994-11-28
FI922874A (fi) 1992-12-21
CN1067656A (zh) 1993-01-06
JPH05202054A (ja) 1993-08-10
AU649331B2 (en) 1994-05-19
ES2095984T3 (es) 1997-03-01
FI922874A0 (fi) 1992-06-18
EP0519291A1 (de) 1992-12-23
MX9202983A (es) 1992-12-01
TW221439B (xx) 1994-03-01
ATE147388T1 (de) 1997-01-15
NZ243191A (en) 1994-04-27
JP3135170B2 (ja) 2001-02-13
CA2071398A1 (en) 1992-12-21
HUT64959A (en) 1994-03-28
AU1739292A (en) 1992-12-24
DE4120322A1 (de) 1992-12-24
CZ177892A3 (en) 1993-02-17
NO922198L (no) 1992-12-21
US5250540A (en) 1993-10-05
KR930000520A (ko) 1993-01-15
NO922198D0 (no) 1992-06-04
RU2044737C1 (ru) 1995-09-27
EP0519291B1 (de) 1997-01-08
DK0519291T3 (da) 1997-06-09
IL102227A0 (en) 1993-01-14
HU9202066D0 (en) 1992-09-28
IE922004A1 (en) 1992-12-30
DE59207824D1 (de) 1997-02-20
GR3022557T3 (en) 1997-05-31

Similar Documents

Publication Publication Date Title
IL97912A0 (en) Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
HUP9701096A3 (en) Use of benzenesulfonamides for the preparation of pharmaceutical compositions treating disorders of the central nervous system, novel derivatives, process for their preparation and pharmaceutical compositions containing them
IL104006A0 (en) Azaheterocyclylmethyl-chromans,their preparation and pharmaceutical compositions containing them
HU9203383D0 (en) 2-amino-methyl-chromane derivatives and method for producing said compounds and pharmaceutical preparatives containing them
TW221056B (xx)
EP0261977A3 (en) Catechol derivatives, and preventive and remedial preparations for regressive disorders in the central nervous system
ZA924517B (en) Aminomethyl-substituted 2,3-dihydropyrano(2,3-b)pyridines,process for their preparation and their use in medicaments
IL93988A0 (en) Substituted 1,8-naphthyridines,their preparation and medicaments comprising them
MY105555A (en) Heterocyclicguanidines as 5ht 3 antagonists.
IL95376A0 (en) Pyrido(3,4-b)(1,4)-benzoxazepines,process for their preparation and their use as medicaments
PH19051A (en) 8-(3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl)-1-phenyl-1,3,8-triazaspiro-(4.5)decan-4-ones,process for the preparation and pharmaceutical composition thereof
DE3370794D1 (en) Halogenated aromatic diamines, process for their preparation and their use in the preparation of polyurethanes
HUT49054A (en) Process for producing pharmaceutical compositions absorbed through the derm and comprising pyrazolo(1,5-a) pyridine derivatives as active ingredient
ES8203900A1 (es) Procedimiento para la obtencion de 7,8,9,10-tetrahidrofuro (3,2-e)pirido (4,3-b)indoles